https://doi.org/10.4081/monaldi.2023.2803
Allergic bronchopulmonary aspergillosis: radiological and microbiological profile of patients presented in an outpatient pulmonary clinic in a developing country
Submitted: October 7, 2023
Accepted: November 9, 2023
Published: December 7, 2023
Accepted: November 9, 2023
Abstract Views: 485
PDF_EARLY VIEW: 268
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
There is limited data available about allergic bronchopulmonary aspergillosis (ABPA) in Pakistan. The aim of the study was to describe the radiological and microbiological profile of ABPA patients presenting to the outpatient pulmonary clinic of a tertiary care hospital in Karachi, Pakistan. A retrospective study was conducted on ABPA patients who presented to the pulmonary outpatient clinic at Aga Khan University Hospital, Karachi, Pakistan, from January 2017 to December 2019. Data was collected on microbiology and radiology features on predesigned proforma. A total of 7759 asthmatic patients presented at the outpatient pulmonology clinic during the study period. Of the 245 patients labeled as ABPA, 167 fulfilled the inclusion criteria, and 91 (54.5%) were female (mean age 41.9±13.0 years). A high resolution computed tomography scan of the chest was available for 126 patients. Of these, 104 (82.5%) patients had bronchiectasis. Central bronchiectasis was noted in 98 (94.2%), mucus plugging in 71 (56.3%), and hyperinflation was seen in 30 (23.4%) patients. Microbiological testing was available in 103/167 (61.7%) patients. The most common bacterial pathogen was Pseudomonas aeruginosa 32 (31.1%), followed by Hemophilus influenzae 16 (15.5%), and Moraxella catarrhalis 7 (9.7%). Aspergillus fumigatus 17 (23.6%) was the most common mold, followed by Aspergillus flavus 16 (22.2%) and Aspergillus niger 11 (15.3%). Co-infection (bacterial and fungal) was found in 18 (17.45%) patients. Bronchiectasis was frequently observed in our cohort of patients with ABPA. Pseudomonas aeruginosa was found to be common among bacterial pathogens. Isolation of fungus is not uncommon in these patients.
Hassanzad M, Mortezaee V, Bongomin F, et al. Successful control of exacerbation of allergic bronchopulmonary aspergillosis due to Aspergillus terreus in a cystic fibrosis patient with short-term adjunctive therapy with voriconazole: a case report. J Mycol Med 2019;29:189-92.
DOI: https://doi.org/10.1016/j.mycmed.2019.02.001
Rosenberg M, Patterson R, Mintzer R, et al. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977;86:405-14.
DOI: https://doi.org/10.7326/0003-4819-86-4-405
Wang JL, Patterson R, Rosenberg M, et al. Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1978;117:917-27.
Agarwal R, Chakrabarti A, Shah A, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy 2013;43:850-73.
DOI: https://doi.org/10.1111/cea.12141
Amini B, El-Feky M, et al. Allergic bronchopulmonary aspergillosis. Reference Article. 2008. Available from: https://radiopaedia.org/articles/allergic-bronchopulmonary-aspergillosis.
Patil S, Patil R. “Fleeting pulmonary infiltrates in allergic bronchopulmonary aspergillosis” misdiagnosed as tuberculosis. Int J Mycobacteriol 2018;7:186-90.
DOI: https://doi.org/10.4103/ijmy.ijmy_57_18
Le Thuong V, Nguyen Ho L, Tran Van N. Allergic bronchopulmonary aspergillosis masquerading as recurrent bacterial pneumonia. Med Mycol Case Rep 2016;12:11-3.
DOI: https://doi.org/10.1016/j.mmcr.2016.06.004
Patterson R, Greenberger PA, Halwig JM, et al. Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 1986;146:916-8.
DOI: https://doi.org/10.1001/archinte.146.5.916
Oguma T, Taniguchi M, Shimoda T, et al. Allergic bronchopulmonary aspergillosis in Japan: a nationwide survey. Allergol Int 2018;67:79-84.
DOI: https://doi.org/10.1016/j.alit.2017.04.011
Chakrabarti A, Sethi S, Raman DSV, Behera D. Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital. Mycoses 2002;45:295-9.
DOI: https://doi.org/10.1046/j.1439-0507.2002.00738.x
Angrill J, Agustí C, de Celis R, et al. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 2002;57:15-19.
DOI: https://doi.org/10.1136/thorax.57.1.15
Denning DW, Pleuvry A, Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 2013;51:361-70.
DOI: https://doi.org/10.3109/13693786.2012.738312
Jabeen K, Farooqi J, Mirza S, et al. Serious fungal infections in Pakistan. Eur J Clin Microbiol Infect Dis 2017;36:949-56.
DOI: https://doi.org/10.1007/s10096-017-2919-6
Kumar R, Goel N. Allergic bronchopulmonary aspergillosis: a clinico-serological correlation with radiologic profile. J Asthma 2013;50:759-63.
DOI: https://doi.org/10.3109/02770903.2013.796973
Agarwal R, Khan A, Garg M, et al. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol 2012;4:141-50.
DOI: https://doi.org/10.4329/wjr.v4.i4.141
Zhang M, Gao J. Clinical analysis of 77 patients with allergic bronchopulmonary aspergillosis in Peking union medical college hospital. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2017;39:352-7.
Lou B, Xu Z, Yang G, et al. Role of Aspergillus fumigatus-specific IgE in the diagnosis of allergic bronchopulmonary aspergillosis. Int Arch Allergy Immunol 2019;178:338-44.
DOI: https://doi.org/10.1159/000495365
Chowdhary A, Agarwal K, Kathuria S, et al. Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview. Crit Rev Microbiol 2014;40:30-48.
DOI: https://doi.org/10.3109/1040841X.2012.754401
Agarwal R, Khan A, Aggarwal AN, et al. Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary aspergillosis. J Infect Public Health 2011;4:235-43.
DOI: https://doi.org/10.1016/j.jiph.2011.08.006
Patterson R, Greenberger PA, Radin RC, Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med 1982;96:286-91.
DOI: https://doi.org/10.7326/0003-4819-96-3-286
Greenberger PA, Yucha CB, Janson S, Huss K. Using rare diseases as models for biobehavioral research: allergic bronchopulmonary aspergillosis. Allergy Asthma Proc 2007;28:489-96.
DOI: https://doi.org/10.2500/aap.2007.28.3023
Edwards MR, Bartlett NW, Hussell T, et al. The microbiology of asthma. Nat Rev Microbiol 2012;10:459-71.
DOI: https://doi.org/10.1038/nrmicro2801
Shah A, Panjabi C. Allergic bronchopulmonary aspergillosis: a perplexing clinical entity. Allergy Asthma Immunol Res 2016;8:282-97.
DOI: https://doi.org/10.4168/aair.2016.8.4.282
Ethics Approval
The study protocol was approved by the Ethical Review Committee of the Aga Khan University Hospital. ERC number assigned 2019-0901- 2239.How to Cite
Iqbal, Nousheen, Muhammad Irfan, Mustafa Bin Ali Zubairi, Maaha Ayub, Safia Awan, Kausar Jabeen, and Ali Bin Sarwar Zubairi. 2023. “Allergic Bronchopulmonary Aspergillosis: Radiological and Microbiological Profile of Patients Presented in an Outpatient Pulmonary Clinic in a Developing Country”. Monaldi Archives for Chest Disease, December. https://doi.org/10.4081/monaldi.2023.2803.
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Saroj Kumari Meena, Rajnish Gupta, Manmohan Puri, Existence and pattern of sleep-related breathing disorders in patients diagnosed with bronchial asthma , Monaldi Archives for Chest Disease: Early Access
- I. Chkhaidze, T. Maglakelidze, N. Khaltaev, Chronic respiratory diseases at primary health care level in Georgia: the results of the pilot study , Monaldi Archives for Chest Disease: Vol. 71 No. 4 (2009): Pulmonary series
- F.J. Gonzalez Barcala, A. Pena, L. Herrero, A. Urtaza, M. GarcÃa DomÃnguez, L. Valdes Cuadrado, Young man with asthma and infertility , Monaldi Archives for Chest Disease: Vol. 71 No. 4 (2009): Pulmonary series
- Massimiliano Polastri, Lara Pisani, Andrea Dell'Amore, Stefano Nava, Revolving door respiratory patients: A rehabilitative perspective , Monaldi Archives for Chest Disease: Vol. 87 No. 3 (2017)
- M. Bocchino, E. Barra, F. Lassandro, F. Ranieri, R. Muto, G. Rea, Primary pleural haemangioendothelioma in an Italian female patient: a case report and review of the literature , Monaldi Archives for Chest Disease: Vol. 73 No. 3 (2010): Pulmonary series
- Mehmet Erdem Çakmak, Saltuk Buğra Kaya, Özge Can Bostan, Ebru Damadoğlu, Gül Karakaya, Ali Fuat Kalyoncu, Short- and long-term oral steroid therapy in patients with asthma exacerbation , Monaldi Archives for Chest Disease: Vol. 93 No. 1 (2023)
- Maral Ranjbar, Mojdeh Matloubi, Shaghayegh Sadegh, Morteza Fallahpour, Leila Janani, Mohammad-Ali Assarehzadegan, IL1RL1 single nucleotide polymorphisms are associated with asthma in the Iranian population , Monaldi Archives for Chest Disease: Vol. 92 No. 3 (2022)
- G. Passalacqua, E. Compalati, M. Schiappoli, G. Senna, Complementary and alternative medicine for the treatment and diagnosis of asthma and allergic diseases , Monaldi Archives for Chest Disease: Vol. 63 No. 1 (2005): Pulmonary series
- Monia Attia, Houda Gharsalli, Haifa Rmili, Meriem Affes, Soumaya Ben Saad, Sarra Zairi, Ines Baccouche, Saoussen Hantous, Henda Neji, Khaoula Ben Miled-M’rad, Spontaneous hemothorax and neurofibromatosis type 1: How to explain it, how to explore it and how to treat it? , Monaldi Archives for Chest Disease: Vol. 89 No. 2 (2019)
- Seyed Hamid Borsi, Seyed Ali Asghar Fakhr Mousavi Fakhr Mousavi, Mehrdad Dargahi Mal-Amir, Heshmatollah Tavakol, Hanieh Raji, Evaluation of the effectiveness of Tadalafil on improving pulmonary function and asthma severity in severe asthmatic patients: a randomized controlled trial study , Monaldi Archives for Chest Disease: Early Access
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
